Viewing Study NCT05511051


Ignite Creation Date: 2025-12-24 @ 11:49 PM
Ignite Modification Date: 2026-01-03 @ 12:02 AM
Study NCT ID: NCT05511051
Status: UNKNOWN
Last Update Posted: 2022-08-22
First Post: 2022-08-19
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Prospective Multi-centered Randomized Controlled Trial on Fruquintinib in Combination With HAIC in the Treatment of Liver Metastatic Colorectal Cancer After Failure of Second-line Systematic Therapy
Sponsor: Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Organization:

Organization Data

Organization:
Class: OTHER
Study ID: HMPL-013-N1-CRC102
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type: PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators

Collaborators

Name Class View
None INDUSTRY View